The abstract is read at the publisher; the summary is JClub's.
Replication stress is a central feature of tumour development and progression, arising from multiple DNA-synthesis barriers and linked to genomic instability and mutagenesis.
- Why it matters: Tumours evolve under chronic, sublethal replication stress, but the mechanisms that stabilize and restart stalled replication forks also create exploitable therapeutic dependencies.
- What they did: The review synthesizes recent mechanistic work on replication-fork stabilization and restart, emphasizing the ATR–CHK1 pathway’s role in limiting single-stranded DNA accumulation and catastrophic genome fragmentation.
- The result: It highlights clinical ATR, CHK1, and WEE1 inhibition strategies and synthetic lethal approaches, including PARP inhibition in BRCA1- or BRCA2-deficient tumours and WRN inhibition in microsatellite-unstable cancers.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.